Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases

K Wang, Z Weng, L Sun, J Sun, SF Zhou… - … and biophysical research …, 2015 - Elsevier
K Wang, Z Weng, L Sun, J Sun, SF Zhou, L He
Biochemical and biophysical research communications, 2015Elsevier
Adverse drug reaction (ADR) is of great importance to both regulatory agencies and the
pharmaceutical industry. Various techniques, such as quantitative structure–activity
relationship (QSAR) and animal toxicology, are widely used to identify potential risks during
the preclinical stage of drug development. Despite these efforts, drugs with safety liabilities
can still pass through safety checkpoints and enter the market. This situation raises the
concern that conventional chemical structure analysis and phenotypic screening are not …
Abstract
Adverse drug reaction (ADR) is of great importance to both regulatory agencies and the pharmaceutical industry. Various techniques, such as quantitative structure–activity relationship (QSAR) and animal toxicology, are widely used to identify potential risks during the preclinical stage of drug development. Despite these efforts, drugs with safety liabilities can still pass through safety checkpoints and enter the market. This situation raises the concern that conventional chemical structure analysis and phenotypic screening are not sufficient to avoid all clinical adverse events. Genomic expression data following in vitro drug treatments characterize drug actions and thus have become widely used in drug repositioning. In the present study, we explored prediction of ADRs based on the drug-induced gene-expression profiles from cultured human cells in the Connectivity Map (CMap) database. The results showed that drugs inducing comparable ADRs generally lead to similar CMap expression profiles. Based on such ADR-gene expression association, we established prediction models for various ADRs, including severe myocardial and infectious events. Drugs with FDA boxed warnings of safety liability were effectively identified. We therefore suggest that drug-induced gene expression change, in combination with effective computational methods, may provide a new dimension of information to facilitate systematic drug safety evaluation.
Elsevier